Advanced neuroimaging in stroke patients: Prediction of tissue fate and hemorrhagic transformation

Expert Review of Cardiovascular Therapy

Volumn 10, Issue 4, 2012, Pages 515-524

  Hoffmann, Angelika ^a   Zhu, Guangming ^a   Wintermark, Max ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

blood brain barrier permeability; computed tomography; hemorrhagic transformation; ischemic penumbra; MRI; stroke

Indexed keywords

ALTEPLASE;

BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN TISSUE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC PROCEDURE; DIFFUSION WEIGHTED IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; FLUID ATTENUATED INVERSION; GRADIENT RECALLED ECHO NUCLEAR MAGNETIC RESONANCE IMAGING; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL DECISION MAKING; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERFUSION WEIGHTED IMAGING; REVIEW; STROKE; TREATMENT PLANNING;

CEREBRAL HEMORRHAGE; HUMANS; NEUROIMAGING; STROKE;

EID: 84859451185     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.12.30     Document Type: Review

References (87)

1. Adams HP Jr, Bendixen BH, Kappelle LJ et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Trial of Org 10172 in Acute Stroke Treatment (TOAST). Stroke 24(1), 35-41 (1993). (Pubitemid 23014379)
2. Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischaemia: Molecular pathophysiology and theoretical implications. Lancet Neurol. 6(3), 258-268 (2007). (Pubitemid 46228081)
3. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 355(9216), 1670-1674 (2000). (Pubitemid 30248478)
4. Merino JG, Warach S. Imaging of acute stroke. Nat. Rev. Neurol. 6(10), 560-571 (2010).
5. Wardlaw JM, Mielke O. Early signs of brain infarction at CT: Observer reliability and outcome after thrombolytic treatment - systematic review. Radiology 235(2), 444-453 (2005). (Pubitemid 40571081)
6. Chalela JA, Kidwell CS, Nentwich LM et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: A prospective comparison. Lancet 369(9558), 293-298 (2007). (Pubitemid 46136489)
7. Schellinger PD, Bryan RN, Caplan LR et al. Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 75(2), 177-185 (2010).
8. Hjort N, Christensen S, Solling C et al. Ischemic injury detected by diffusion imaging 11 minutes after stroke. Ann. Neurol. 58(3), 462-465 (2005). (Pubitemid 41266634)
9. Inatomi Y, Kimura K, Yonehara T, Fujioka S, Uchino M. DWI abnormalities and clinical characteristics in TIA patients. Neurology 62(3), 376-380 (2004). (Pubitemid 38200846)
10. Forster A, Gass A, Kern R et al. Brain imaging in patients with transient ischemic attack: A comparison of computed tomography and magnetic resonance imaging. Eur. Neurol. 67(3), 136-141 (2012).
11. Baird AE, Benfield A, Schlaug G et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann. Neurol. 41(5), 581-589 (1997). (Pubitemid 27212651)
12. Schwamm LH, Koroshetz WJ, Sorensen AG et al. Time course of lesion development in patients with acute stroke: Serial diffusion- and hemodynamic-weighted magnetic resonance imaging. Stroke 29(11), 2268-2276 (1998). (Pubitemid 28511943)
13. Lansberg MG, O'Brien MW, Tong DC, Moseley ME, Albers GW. Evolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imaging. Arch. Neurol. 58(4), 613-617 (2001). (Pubitemid 32295713)
14. Campbell BC, Purushotham A, Christensen S et al. The infarct core is well represented by the acute diffusion lesion: Sustained reversal is infrequent. J. Cereb. Blood Flow Metab. 32(1), 50-56 (2012).
15. Ozsunar Y, Sorensen AG. Diffusion- and perfusion-weighted magnetic resonance imaging in human acute ischemic stroke: Technical considerations. Top. Magn. Reson. Imaging 11(5), 259-272 (2000). (Pubitemid 32199430)
16. Sanak D, Nosal V, Horak D et al. Impact of diffusion-weighted MRI-measured initial cerebral infarction volume on clinical outcome in acute stroke patients with middle cerebral artery occlusion treated by thrombolysis. Neuroradiology 48(9), 632-639 (2006). (Pubitemid 44355773)
17. Yoo AJ, Verduzco LA, Schaefer PW, Hirsch JA, Rabinov JD, Gonzalez RG. MRI-based selection for intra-arterial stroke therapy: Value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke 40(6), 2046-2054 (2009).
18. Kang DW, Chalela JA, Ezzeddine MA, Warach S. Association of ischemic lesion patterns on early diffusion-weighted imaging with TOAST stroke subtypes. Arch. Neurol. 60(12), 1730-1734 (2003). (Pubitemid 37521627)
19. Fiebach JB, Schellinger PD, Gass A et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: A multicenter study on the validity of stroke imaging. Stroke 35(2), 502-506 (2004). (Pubitemid 38174437)
20. Thijs V, Lemmens R, Schoofs C et al. Microbleeds and the risk of recurrent stroke. Stroke 41(9), 2005-2009 (2010).
21. Bokura H, Saika R, Yamaguchi T et al. Microbleeds are associated with subsequent hemorrhagic and ischemic stroke in healthy elderly individuals. Stroke 42(7), 1867-1871 (2011).
22. Boulanger JM, Coutts SB, Eliasziw M et al. Cerebral microhemorrhages predict new disabling or fatal strokes in patients with acute ischemic stroke or transient ischemic attack. Stroke 37(3), 911-914 (2006). (Pubitemid 43731932)
23. Latchaw RE, Alberts MJ, Lev MH et al. Recommendations for imaging of acute ischemic stroke: A scientific statement from the American Heart Association. Stroke 40(11), 3646-3678 (2009).
24. Thomalla G, Rossbach P, Rosenkranz M et al. Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less. Ann. Neurol. 65(6), 724-732 (2009).
25. Campbell BC, Costello C, Christensen S et al. Fluid-attenuated inversion recovery hyperintensity in acute ischemic stroke may not predict hemorrhagic transformation. Cerebrovasc. Dis. 32(4), 401-405 (2011).
26. Leys D, Pruvo JP, Godefroy O, Rondepierre P, Leclerc X. Prevalence and significance of hyperdense middle cerebral artery in acute stroke. Stroke 23(3), 317-324 (1992).
27. Kim EY, Lee SK, Kim DJ et al. Detection of thrombus in acute ischemic stroke: Value of thin-section noncontrast-computed tomography. Stroke 36(12), 2745-2747 (2005).
28. Riedel CH, Zimmermann P, Jensen-Kondering U, Stingele R, Deuschl G, Jansen O. The importance of size: Successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke 42(6), 1775-1777 (2011).
29. Schellinger PD, Chalela JA, Kang DW, Latour LL, Warach S. Diagnostic and prognostic value of early MR imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator AJNR Am. J. Neuroradiol. 26 3 618-624 2005 (Pubitemid 43085968)
30. Lee KY, Latour LL, Luby M, Hsia AW, Merino JG, Warach S. Distal hyperintense vessels on FLAIR: An MRI marker for collateral circulation in acute stroke? Neurology 72(13), 1134-1139 (2009).
31. Bash S, Villablanca JP, Jahan R et al. Intracranial vascular stenosis and occlusive disease: Evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am. J. Neuroradiol. 26(5), 1012-1021 (2005). (Pubitemid 43821943)
32. Tan JC, Dillon WP, Liu S, Adler F, Smith WS, Wintermark M. Systematic comparison of perfusion-CT and CT-angiography in acute stroke patients. Ann. Neurol. 61(6), 533-543 (2007). (Pubitemid 47068135)
33. Lev MH, Farkas J, Rodriguez VR et al. CT angiography in the rapid triage of patients with hyperacute stroke to intra-arterial thrombolysis: Accuracy in the detection of large vessel thrombus. J. Comput. Assist. Tomogr. 25(4), 520-528 (2001). (Pubitemid 33041507)
34. Miteff F, Levi CR, Bateman GA, Spratt N, Mcelduff P, Parsons MW. The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke. Brain 132(Pt 8), 2231-2238 (2009).
35. Mcverry F, Liebeskind DS, Muir KW. Systematic review of methods for assessing leptomeningeal collateral flow. AJNR Am. J. Neuroradiol. doi:10.3174/ajnr.A2794 (2012) (Epub ahead of print).
36. Debrey SM, Yu H, Lynch JK et al. Diagnostic accuracy of magnetic resonance angiography for internal carotid artery disease: A systematic review and meta-ana- lysis. Stroke 39(8), 2237-2248 (2008).
37. Alfke K, Jensen U, Pool C et al. Contrast-enhanced magnetic resonance angiography in stroke diagnostics: Additional information compared with time-of-flight magnetic resonance angiography? Clin. Neuroradiol. 21(1), 5-10 (2011).
38. Schievink WI. Spontaneous dissection of the carotid and vertebral arteries. N. Engl. J. Med. 344(12), 898-906 (2001). (Pubitemid 32224399)
39. Dani KA, Thomas RG, Chappell FM et al. Computed tomography and magnetic resonance perfusion imaging in ischemic stroke: Definitions and thresholds. Ann. Neurol. 70(3), 384-401 (2011).
40. Pollock JM, Tan H, Kraft RA, Whitlow CT, Burdette JH, Maldjian JA. Arterial spin-labeled MR perfusion imaging: Clinical applications. Magn. Reson. Imaging Clin. N. Am. 17(2), 315-338 (2009).
41. Grandin CB. Assessment of brain perfusion with MRI: Methodology and application to acute stroke. Neuroradiology 45(11), 755-766 (2003). (Pubitemid 37455669)
42. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn. Reson. Med. 14(2), 249-265 (1990). (Pubitemid 20248610)
43. Smith AM, Grandin CB, Duprez T, Mataigne F, Cosnard G. Whole brain quantitative CBF and CBV measurements using MRI bolus tracking: Comparison of methodologies. Magn. Reson. Med. 43(4), 559-564 (2000). (Pubitemid 30191079)
44. Kiselev VG. On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI. Magn. Reson. Med. 46(6), 1113-1122 (2001). (Pubitemid 33104300)
45. Knutsson L, Stahlberg F, Wirestam R. Absolute quantification of perfusion using dynamic susceptibility contrast MRI: Pitfalls and possibilities. MAGMA 23(1), 1-21 (2010).
46. Kane I, Carpenter T, Chappell F et al. Comparison of 10 different magnetic resonance perfusion imaging processing methods in acute ischemic stroke: Effect on lesion size, proportion of patients with diffusion/perfusion mismatch, clinical scores, and radiologic outcomes. Stroke 38(12), 3158-3164 (2007). (Pubitemid 350175730)
47. Christensen S, Mouridsen K, Wu O et al. Comparison of 10 perfusion MRI parameters in 97 sub-6-hour stroke patients using voxel-based receiver operating characteristics analysis. Stroke 40(6), 2055-2061 (2009).
48. Schlaug G, Benfield A, Baird AE et al. The ischemic penumbra: Operationally defined by diffusion and perfusion MRI. Neurology 53(7), 1528-1537 (1999). (Pubitemid 29491949)
49. Jansen O, Schellinger P, Fiebach J, Hacke W, Sartor K. Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet 353(9169), 2036-2037 (1999). (Pubitemid 29271751)
50. Albers GW, Thijs VN, Wechsler L et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann. Neurol. 60(5), 508-517 (2006). (Pubitemid 44871793)
51. Furlan AJ, Eyding D, Albers Gw et al. Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 37(5), 1227-1231 (2006). (Pubitemid 43731867)
52. Hacke W, Albers G, Al-Rawi Y et al. The Desmoteplase in Acute Ischemic Stroke trial (DIAS): A Phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36(1), 66-73 (2005). (Pubitemid 40054177)
53. Hacke W, Furlan AJ, Al-Rawi Y et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): A prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol. 8(2), 141-150 (2009).
54. Davis SM, Donnan GA, Parsons MW et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): A placebo-controlled randomised trial. Lancet Neurol. 7(4), 299-309 (2008).
55. Nagakane Y, Christensen S, Brekenfeld C et al. EPITHET: Positive result after reanalysis using baseline diffusion-weighted imaging/perfusion-weighted imaging co-Registration. Stroke 42(1), 59-64 (2011).
56. Lansberg MG, Lee J, Christensen S et al. RAPID automated patient selection for reperfusion therapy: A pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study. Stroke 42(6), 1608-1614 (2011).
57. Berger C, Fiorelli M, Steiner T et al. Hemorrhagic transformation of ischemic brain tissue: Asymptomatic or symptomatic? Stroke 32(6), 1330-1335 (2001). (Pubitemid 32530418)
58. Saver JL. Hemorrhage after thrombolytic therapy for stroke: The clinically relevant number needed to harm. Stroke 38(8), 2279-2283 (2007). (Pubitemid 47457569)
59. Gumbinger C, Gruschka P, Bottinger M et al. Improved prediction of poor outcome after thrombolysis using conservative definitions of symptomatic hemorrhage. Stroke 43(1), 240-242 (2012).
60. Hacke W, Kaste M, Fieschi C et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 352(9136), 1245-1251 (1998). (Pubitemid 28470336)
61. Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359(13), 1317-1329 (2008).
62. No authors listed. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med. 333(24), 1581-1587 (1995).
63. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-Type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 282(21), 2019-2026 (1999).
64. Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: Results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 172(10), 1307-1312 (2005). (Pubitemid 40745072)
65. Shobha N, Buchan AM, Hill MD. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset - evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry. Cerebrovasc. Dis. 31(3), 223-228 (2011).
66. Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282(21), 2003-2011 (1999).
67. Smith WS, Sung G, Starkman S et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial. Stroke 36(7), 1432-1438 (2005). (Pubitemid 40967507)
68. Smith WS, Sung G, Saver J et al. Mechanical thrombectomy for acute ischemic stroke: Final results of the Multi MERCI trial. Stroke 39(4), 1205-1212 (2008). (Pubitemid 351440692)
69. IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke 38(7), 2127-2135 (2007).
70. Wang X, Lo EH. Triggers and mediators of hemorrhagic transformation in cerebral ischemia. Mol. Neurobiol. 28(3), 229-244 (2003). (Pubitemid 38156421)
71. Kim EY, Na DG, Kim SS, Lee KH, Ryoo JW, Kim HK. Prediction of hemorrhagic transformation in acute ischemic stroke: Role of diffusion-weighted imaging and early parenchymal enhancement. AJNR Am. J. Neuroradiol. 26(5), 1050-1055 (2005). (Pubitemid 43821947)
72. Merten CL, Knitelius HO, Assheuer J, Bergmann-Kurz B, Hedde JP, Bewermeyer H. MRI of acute cerebral infarcts, increased contrast enhancement with continuous infusion of gadolinium. Neuroradiology 41(4), 242-248 (1999). (Pubitemid 29195257)
73. Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S. Early blood-brain barrier disruption in human focal brain ischemia. Ann. Neurol. 56(4), 468-477 (2004). (Pubitemid 39319336)
74. Vo KD, Santiago F, Lin W, Hsu CY, Lee Y, Lee JM. MR imaging enhancement patterns as predictors of hemorrhagic transformation in acute ischemic stroke. AJNR Am. J. Neuroradiol. 24(4), 674-679 (2003). (Pubitemid 36460739)
75. Kastrup A, Groschel K, Ringer TM et al. Early disruption of the blood-brain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke. Stroke 39(8), 2385-2387 (2008).
76. Hom J, Dankbaar JW, Schneider T, Cheng SC, Bredno J, Wintermark M. Optimal duration of acquisition for dynamic perfusion CT assessment of blood-brain barrier permeability using the Patlak model. AJNR Am. J. Neuroradiol. 30(7), 1366-1370 (2009).
77. Aviv RI, D'Esterre CD, Murphy BD et al. Hemorrhagic transformation of ischemic stroke: Prediction with CT perfusion. Radiology 250(3), 867-877 (2009).
78. Hom J, Dankbaar JW, Soares BP et al. Blood-brain barrier permeability assessed by perfusion CT predicts symptomatic hemorrhagic transformation and malignant edema in acute ischemic stroke. AJNR Am. J. Neuroradiol. 32(1), 41-48 (2011).
79. Kassner A, Roberts T, Taylor K, Silver F, Mikulis D. Prediction of hemorrhage in acute ischemic stroke using permeability MR imaging. AJNR Am. J. Neuroradiol. 26(9), 2213-2217 (2005).
80. Vidarsson L, Thornhill RE, Liu F, Mikulis DJ, Kassner A. Quantitative permeability magnetic resonance imaging in acute ischemic stroke: How long do we need to scan? Magn. Reson. Imaging 27(9), 1216-1222 (2009).
81. Bang OY, Buck BH, Saver JL et al. Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging. Ann. Neurol. 62(2), 170-176 (2007). (Pubitemid 47546502)
82. Lee M, Hong KS, Saver JL. Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: Meta-analysis of randomized controlled trials. Stroke 41(5), 932-937 (2010).
83. Mazighi M, Serfaty JM, Labreuche J et al. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): A prospective cohort study. Lancet Neurol. 8(9), 802-809 (2009).
84. Soares BP, Tong E, Hom J et al. Reperfusion is a more accurate predictor of follow-up infarct volume than recanalization: A proof of concept using CT in acute ischemic stroke patients. Stroke 41(1), e34-e40 (2010).
85. Bang OY, Saver JL, Buck BH et al. Impact of collateral flow on tissue fate in acute ischaemic stroke. J. Neurol. Neurosurg. Psychiatry 79(6), 625-629 (2008). (Pubitemid 351829431)
86. Campbell BC, Christensen S, Butcher KS et al. Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusion-weighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke. Stroke 41(1), 82-88 (2010).
87. von Kummer R, Bourquain H, Bastianello S et al. Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology 219(1), 95-100 (2001). (Pubitemid 32234059)